Next Article in Journal
Unique Properties of Nutrient Channels on Plasmodium-Infected Erythrocytes
Next Article in Special Issue
Brucellosis Seropositivity Using Three Serological Tests and Associated Risk Factors in Abattoir Workers in Gauteng Province, South Africa
Previous Article in Journal
Risks of Brucella spp. Infection in Dogs
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Pasteurella Multocida Infection in Humans

by
Marcin Piorunek
1,*,
Beata Brajer-Luftmann
2 and
Jarosław Walkowiak
3
1
Veterinary Practice Marcin Piorunek, 60-185 Skórzewo, Poland
2
Department of Pulmonology, Allergology and Pulmonary Oncology, Poznań University of Medical Sciences, 60-569 Poznań, Poland
3
Department of Pediatric Gastroenterology and Metabolic Diseases, Poznań University of Medical Sciences, 60-572 Poznań, Poland
*
Author to whom correspondence should be addressed.
Pathogens 2023, 12(10), 1210; https://doi.org/10.3390/pathogens12101210
Submission received: 24 August 2023 / Revised: 26 September 2023 / Accepted: 28 September 2023 / Published: 1 October 2023
(This article belongs to the Special Issue Bacterial Infections: Surveillance, Prevention and Control)

Abstract

:
Pasteurella multocida (P. multocida) is an immobile, anaerobic, Gram-negative coccobacillus fermenting bacterium. This pathogen is commonly prevalent in the upper airways of healthy pets, such as cats and dogs, but was also confirmed in domestic cattle, rabbits, pigs, birds, and various wild animals. Infection in humans occurs as a result of biting, scratching, or licking by animals and contact with nasopharyngeal secretions. Inflammation at the site of infection develops within the first day from the injury. It is usually confined to the skin and subcutaneous tissue but, in particular situations, may spread to other organs and manifest as a severe systemic infection. Careful history-taking and microbiological confirmation of the infection enable diagnosis and appropriate treatment. Any wound resulting from an animal bite should be disinfected. The preferred and highly effective treatment against local P. multocida infection is penicillin or its derivatives. The prognosis for P. multocida infections depends on the infected site and the patient’s comorbidities.

1. Introduction

Pasteurella multocida (P. multocida) is an immobile, anaerobic, Gram-negative coccobacillus fermenting bacterium belonging to the Pasteurellaceae family [1]. This bacterium was first isolated by Kitt in 1878 during an epidemic disease among wild hogs and two years later, described by Pasteur as fowl cholera [2]. In his honor, the bacterium was named Pasteurella [3]. P. multocida has been serologically classified into five commonly isolated serogroups (A, B, D, E, and F) according to the composition of the polysaccharide capsule and 16 lipopolysaccharides (LPS) serovars using Carter’s and Heddleston’s methods [4,5,6,7]. It is known that the subtypes of P. multocida differ in their virulence. Most infections are caused by serogroups A and D, and the most important contributors to bacterial virulence are the polysaccharide capsule, the surface lipopolysaccharide molecule, iron acquisition proteins, and P. multocida toxin [8]. Recently, attempts have been made to assess the virulence of this pathogen using genetic methods. The availability of P. multocida genome sequences makes it possible to explain the underlying genetic mechanisms of P. multocida fitness and virulence using whole-genome sequences, genotypes, including the capsular genotypes, lipopolysaccharide (LPS) genotypes, and multilocus sequence typing, as well as virulence factor-encoding genes of P. multocida isolates [9,10].
P. multocida is commonly prevalent in various parts of the upper airways of healthy pets, most often cats and dogs, but it was also confirmed in domestic cattle, rabbits, pigs, birds, and wild animals. On the other hand, P. multocida may be associated with numerous serious, acute, or chronic diseases in a wide range of animal species, including fowl cholera, bovine hemorrhagic septicemia, enzootic pneumonia of cattle, porcine atrophic rhinitis, and pasteurellosis in pigs [11]. The infection is transmitted to humans most commonly by cats and dogs, with carrier rates of 70% to 90% and 20% to 50%, respectively [1]. In 2021, purebred cats and mixed breeds were the most frequently chosen pet in the European Union (EU), and their number that year was estimated at 113 million [12]. Poland ranked 6th with an estimated 4.082 million cats [13]. The number of domestic dogs in the EU in 2021 has been estimated at over 92 million, and in Poland at 6.466 million [14]. A questionnaire study on the characteristics of the population of dogs and cats in Poland showed that 50% of the inhabitants are dog owners. The percentage of people who own cats is smaller but also significant and amounts to 37% [15].

2. The Pathogenesis and Epidemiology of P. multocida Infection

Transmission of infection from animal to human occurs through biting, scratching, or licking. Four to five million animal bite wounds are reported annually in the USA, resulting in approximately 300,000 emergency department visits [16]. The bacteria are isolated from approx. 50% of wounds caused by dogs and 75% of wounds caused by cats [8]. Minor scratches and bites caused by pets are not reported by the healthcare facility, which is just one reason why it is difficult to determine the prevalence of P. multocida infection in humans. Although the number of bites caused by dogs is clearly higher than those caused by cats, only 3–18% of all dog bites result in a wound infection, compared to 20–80% of cat bite infections. It is also possible to become infected without direct human–animal contact, such as contamination of a wound with dog saliva or through socks covered with cat hair and dandruff, as well as by eating food that the animal previously ate. Infection of this type is associated with the presence of comorbidities, and in the worst case, may be life-threatening [17]. There are known single cases of wound infections in humans resulting from bites by tigers, leopards, lynxes, rats, opossums, lions, horses, rabbits, boars, and panthers [18]. Five different species or subspecies cause pasteurellosis in humans, including P. multocida, P. septica, P. canis, P. stomatis, and P. dagmatis. Isolation and identification of the pathogen are not particularly difficult [19]. It is estimated that P. multocida is the most commonly cultured bacterium from infected human wounds [20].

3. Diagnosis of P. multocida in Human

3.1. Clinical Suspicion and Evaluation

Pasteurella spp. should first be considered as a cause of soft tissue infection resulting from scratching, biting, or licking by a cat or dog. The infection is characterized by a rapid onset and intense inflammatory reaction, the course of which is similar to soft tissue infection caused by group A streptococci, such as Streptococcus pyogenes [21,22,23]. Cat bite wounds can penetrate deep into the soft tissues, which is related to the structure of their teeth. Compared to dog bites, this poses a higher risk of osteomyelitis, tenosynovitis, and septic arthritis, as well as septic arthritis of damaged joints and joint prostheses [24]. An important factor for P. multocida infection that should be considered are patients with compromised immunity, liver failure, diabetes, malignant tumors, and severe infections such as pneumonia, meningitis, or bacterial peritonitis who have been exposed to animals [1].

3.2. Microbiological Examination

Diagnosis of P. multocida infection in diagnostic material is possible by isolating the pathogen from a culture, using PCR or serological tests. Due to the antigenic complexity of the bacteria and the undetermined taxonomic status of many Pasteurellaceae, serological methods do not enable the diagnosis of an active infection and are more likely to produce false-positive results compared to viral serology. The biological material for a culture may be a wound swab, sputum, blood, cerebrospinal fluid, synovial fluid, and others, depending on the location of the infection [8].
The recommended medium for growing P. multocida is 5% Columbia Agar with sheep’s blood, maintained at a temperature of 37 degrees Celsius for 24–72 h, in an atmosphere of 10% CO2 [25]. Pathogen identification is performed using some methods, such as Vitek2, VITEK MS, Bruker Biotyper MS tests, and traditional biochemical tests [26]. Drug susceptibility is performed according to the EUCAST standard [27]. A fast, sensitive, specific, and highly effective method for identifying P. multocida and its subspecies is the PCR test. It is an alternative to biochemical methods (fermentation of sorbitol and dulcitol) and others [28].

4. Host-Pathogen Interactions of P. multocida and Clinical Manifestation in Humans

The infection in humans usually has a rapid course. Limited superficial soft tissue infection and abscesses are most commonly reported in healthy individuals. Still, in particular situations, such as immunodeficiencies, P. multocida may spread to other organs and manifest as a severe systemic infection [29]. Inflammation at the site of infection develops within 24 h of injury and is most often confined to the skin and subcutaneous tissue. Bites and scratches caused by a cat usually affect the upper limbs and face. Their narrow, sharp teeth cause a small crack in the skin, which quickly closes up, causing the entrapment of bacteria in deeper tissues [30]. The typical clinical manifestations associated with inflammation include wound-related erythema, tenderness at the wound site, edema, purulent exudate, and cellulitis [31,32,33,34]. As a result of contact with animal secretions, infection of the lower respiratory tract and the development of pneumonia, tracheitis and bronchitis occur relatively often, as well as serious complications such as lung abscess or pleural empyema are possible. The risk factors are old age, chronic respiratory diseases such as COPD or bronchiectasis, and malignant tumors [35]. The prevalence of respiratory tract infections caused by P. multocida in everyday medical practice has not been determined [36]. In a review of 108 patients with P. multocida infection of the respiratory system, 49 cases of pneumonia, 37 of tracheobronchitis, 25 of pleural empyema, and 3 cases of lung abscess were reported [37]. Another study [31] analyzed 136 P. multocida infections non-related to animal bites and found that 80 were related to the respiratory tract of people with chronic lung disease. P. multocida may be a commensal organism in the respiratory system of patients with underlying lung disease. The infection may be mild, and the isolation of the pathogen from the respiratory tract may be random and difficult to interpret [38].
Upper airway pasteurellosis is exceptional and is secondary to oropharyngeal carriage or contamination of the patient’s airways by domestic or farm animals. The transmission mode may be inhalation of infectious nasopharyngeal secretions from cats and dogs. In the available literature, only one fatal case of P. multocida epiglottitis infection with associated septicemia was found [39,40,41].
Fatal P. multocida septicemia and necrotizing fasciitis in patients with gouty arthritis and open wound with tophi licked by an infected domestic dog has also been described [22]. Similarly, prosthetic joint infections (PJI) have rarely been reported in science publications. PJI typically occurs in the context of an animal licking the wound, bite, or scratch. They may be related to perioperative complications of hip or knee arthroplasty, such as hematoma formation, superficial wound infection, wound drainage, and wound dehiscence. Older age, diabetes, rheumatoid arthritis, immunosuppressive therapy, malignancy, and arthroplasty revision have been identified as risk factors [42,43,44,45,46]. A single case of pubic symphysis septic arthritis caused by P. multocida has been described too [47].
Meningitis and bacteremia due to P. multocida are rare, and more frequently observed in infants and infected adults over 60 years old [48,49]. Immunocompromised status, cancer, cirrhosis, diabetes, and chronic obstructive lung disease have been specified as predisposing factors to pasteurellosis. The most common cause of meningitis caused by P. multocida, estimated at almost 90%, is direct contact with an infected animal [50]. Bacterial meningitis is caused by a penetrating bite, skull fracture or skull surgery, and blood-borne bacteremia or a spread of the infection from the surrounding area. It may also be caused by directly licking, sniffing, kissing, or touching the animal [31,51,52,53].
Few interesting reports on cardiovascular infections are available in the literature. P. multocida bacteremia causing aortic valve dysfunction with endocarditis [54,55,56], myopericarditis following a dog bite [57], pericardial tamponade after a cat bite [58], and endocarditis in a patient with intravenous drug abuse were described [59]. Single cases of femoral artery aneurysm with large hematoma caused by P. multocida [60] and infection resulting in a descending thoracic aorta mycotic pseudoaneurysm were described [61]. Positive blood culture results were obtained in each reported case, and direct contact with a domestic animal was confirmed.
There are relatively many reports on P. multocida septicemia in the available scientific sources. The direct causes in the described cases were bites and scratches caused by dogs or cats. In most of the described cases, there were chronic comorbidities significantly worsening the prognosis. These included diabetes, cirrhosis, renal insufficiency, gout arthritis, Cushing’s syndrome, hypertension, dyslipidemia, hypothyroidism, heart failure, chronic kidney disease, immunodeficiencies, obstructive sleep apnea, and morbid obesity. An unfavorable factor in the course of the disease was the older age of the patients; some of them died [22,62,63,64,65,66,67,68,69].
A significant but rare clinical problem is peritonitis caused by P. multocida infection in patients undergoing peritoneal dialysis [70,71,72]. There were reports of urinary tract infection caused by direct contact with dogs and cats [73,74] and P. multocida infection in solid organ transplantation [75]. There were few cases of cholecystitis with positive blood and bile cultures for P. multocida [76], endophthalmitis in the patient with negative history of animal bites or scratch wounds [77], also ulceration on the penis caused by the teeth of a dog that was forced by the man to lick his penis have been described too [78]. A unique case of dental follicle infection following a dog bite [79] and a case of endometritis due to P. multocida in a woman using an intrauterine device and who has everyday contact with cats and dogs were presented in the scientific literature [80].

5. Differential Diagnosis

P. multocida is the most common pathogen isolated from wounds following animal bites or scratches. Other microorganisms such as Bartonella henselae, Clostridium tetani, Staphylococcus aureus, and Rabies lyssavirus should also be taken into account in the differential diagnosis [81].

6. Management

Any wound resulting from an animal bite should be disinfected. Surgical debridement, removal of debris and, in older wounds, removal of abscesses and dead tissue, and prompt use of antibiotics are essential in treating the infection. If the wound is on a limb, it is recommended to position the limb higher to minimize swelling [82,83]. The preferred and highly effective treatment against local P. multocida infection, if cultures cannot be acquired or Pasteurella is not isolated in a culture, is penicillin or its derivatives, such as oral amoxicillin-clavulanate. Rare cases of penicillin-resistant strains of P. multocida have been reported in human infections, and β-lactamase positivity was found in 16 percent of infected individuals [84]. Alternative therapy includes any combination of an antibiotic with anti-Pasteurella activity, such as doxycycline, trimethoprim/sulfamethoxazole, penicillin V, cefuroxime, ciprofloxacin, or levofloxacin, as well as an anti-anaerobic agent (metronidazole or clindamycin) to cover other oral flora. The systemic infection of P. multocida with positive cultures of blood, deep tissues, or respiratory tract yields the need for aggressive antibiotic treatment. The first line of parenteral antibiotic treatment includes monotherapy with ampicillin-sulbactam, piperacillin-tazobactam, or carbapenem (imipenem-cilastatin, meropenem, ertapenem). Ceftriaxone or fluoroquinolone plus an anti-anaerobic agent (such as metronidazole or clindamycin) are also acceptable. Treatment failures have been observed in patients treated with oral erythromycin, semi-synthetic penicillins such as oxacillin, dicloxacillin, as well as first-generation cephalosporins, which include cephalothin, cephalexin and cefadroxil, and clindamycin. These antibiotics have been shown to have poor in vitro activity against P. multocida and are, therefore, not recommended. Resistance to penicillin G, ampicillin, and tetracycline has been observed in cases of chronic pulmonary infection [85]. Antibiotic regimens should always be targeted based on cultures and sensitivities when appropriate. Treatment is usually continued for 5–14 days. The duration of antibiotic treatment should be longer in the case of a slow response or particularly severe disease [81,83].

7. Prophylactics

After being bitten or scratched by an animal, disinfecting and dressing the wound is essential. The primary wound closure should be carried out only if necessary, as this increases the risk of developing an infection, and a space should be left between sutures to allow drainage. Prophylactic antibiotics are not currently routinely recommended. As part of the prevention of pasteurellosis, antibiotic therapy is recommended in immunosuppressed or immunocompromised (i.e., diabetes mellitus, asplenia, cirrhosis, etc.). Amoxicillin-clavulanate is the first-line antibiotic for prophylaxis. Alternative medication for pasteurellosis prophylactics may include any antibiotic, such as doxycycline, trimethoprim/sulfamethoxazole, penicillin V, cefuroxime, ciprofloxacin, or levofloxacin, as well as an anti-anaerobic agent (metronidazole or clindamycin) to cover other oral flora [83,86].

8. Prognosis and One Health Prospective

The prognosis for P. multocida infections is usually successful, but the course of the disease depends on the infected site and the patient’s comorbidities. Most soft tissue infections resolve with the appropriate oral antibiotics and wound drainage when indicated. However, in more severe cases, such as bacteremia, meningitis, and endocarditis, the prognosis is much worse, and the mortality rate is higher (30%) [8].

9. Conclusions

P. multocida infections may affect any organ and system. This infection should be suspected especially in elderly patients with chronic diseases and in frequent contact with domestic animals, primarily cats and dogs. Avoiding bites, scratches, and direct contact with animal saliva is recommended to prevent pasteurellosis. Careful history-taking and microbiological confirmation of the infection enable diagnosis and appropriate treatment. The observed economic and social development as well as the growing material and spiritual needs of humans may be the reason for the increase in the number of domestic animals, such as cats and dogs, and farm animals used for food production. This is why P. multocida may become a factor threatening human health that should not be ignored.

Author Contributions

Conceptualization, M.P.; investigation, M.P.; resources, M.P.; data curation, M.P.; writing—original draft preparation, M.P.; writing—review and editing, B.B.-L. and J.W.; supervision, J.W.; project administration, M.P. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

No new data were created or analyzed in this study. Data sharing is not applicable to this article.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Giordano, A.; Dincman, T.; Clyburn, B.E.; Steed, L.L.; Rockey, D.C. Clinical Features and Outcomes of Pasteurella multocida Infection. Medicine 2015, 94, e1285. [Google Scholar] [CrossRef] [PubMed]
  2. Zurlo, J.J. Pasteurella Species. In Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases; Elsevier Inc.: Amsterdam, The Netherlands, 2014; Volume 2, pp. 2603–2606. [Google Scholar] [CrossRef]
  3. Pasteur, L. The attenuation of the causal agent of fowl cholera 1880. Biology 1999. [Google Scholar]
  4. Rimler, R.B.; Rhoades, K.R. Serogroup F, a new capsule serogroup of Pasteurella multocida. J. Clin. Microbiol. 1987, 25, 615–618. [Google Scholar] [CrossRef]
  5. Carter, G.R. Studies on Pasteurella multocida. I. A hemagglutination test for the identification of serological types. Am. J. Vet. Res. 1955, 16, 481–484. [Google Scholar]
  6. Carter, G.R. Further Observations on Typing Pasteurella multocida by the Indirect Hemagglutination Test. Can. J. Comp. Med. Vet. Sci. 1962, 26, 238–240. [Google Scholar] [PubMed]
  7. Heddleston, K.L.; Gallagher, J.E.; Rebers, P.A. Fowl cholera: Gel diffusion precipitin test for serotyping Pasteurella multocida from avian species. Avian Dis. 1972, 16, 925–936. [Google Scholar] [CrossRef] [PubMed]
  8. Wilson, B.A.; Ho, M. Pasteurella multocida: From zoonosis to cellular microbiology. Clin. Microbiol. Rev. 2013, 26, 631–655. [Google Scholar] [CrossRef]
  9. Davidsen, T.; Rødland, E.A.; Lagesen, K.; Seeberg, E.; Rognes, T.; Tønjum, T. Biased distribution of DNA uptake sequences towards genome maintenance genes. Nucleic Acids Res. 2004, 32, 1050–1058. [Google Scholar] [CrossRef]
  10. Peng, Z.; Wang, X.; Zhou, R.; Chen, H.; Wilson, B.A.; Wu, B. Pasteurella multocida: Genotypes and Genomics. Microbiol. Mol. Biol. Rev. 2019, 83, e00014-19. [Google Scholar] [CrossRef]
  11. Ujvári, B.; Weiczner, R.; Deim, Z.; Terhes, G.; Urbán, E.; Tóth, A.R.; Magyar, T. Characterization of Pasteurella multocida strains isolated from human infections. Comp. Immunol. Microbiol. Infect. Dis. 2019, 63, 37–43. [Google Scholar] [CrossRef]
  12. Statista. Available online: https://www.statista.com/statistics/515464/cat-ownership-european-union-eu-by-country/ (accessed on 5 September 2023).
  13. Statista. Available online: https://www.statista.com/statistics/515410/cat-population-european-union-eu-by-country/ (accessed on 5 September 2023).
  14. Statista. Available online: https://www.statista.com/statistics/414956/dog-population-european-union-eu-by-country/ (accessed on 29 August 2023).
  15. Vetkompleksowo. Available online: https://vetkompleksowo.pl/ (accessed on 2 January 2020).
  16. Martin, T.C.S.; Abdelmalek, J.; Yee, B.; Lavergne, S.; Ritter, M. Pasteurella multocida line infection: A case report and review of literature. BMC Infect. Dis. 2018, 18, 420. [Google Scholar] [CrossRef] [PubMed]
  17. Kannangara, D.W.; Pandya, D.; Patel, P. Pasteurella multocida Infections with Unusual Modes of Transmission from Animals to Humans: A Study of 79 Cases with 34 Nonbite Transmissions. Vector Borne Zoonotic Dis. 2020, 20, 637–651. [Google Scholar] [CrossRef] [PubMed]
  18. Woolfrey, B.F.; Quall, C.O.; Lally, R.T. Pasteurella multocida in an infected tiger bite. Arch. Pathol. Lab. Med. 1985, 109, 744–746. [Google Scholar] [PubMed]
  19. Donnio, P.Y.; Lerestif-Gautier, A.L.; Avril, J.L. Characterization of Pasteurella spp. strains isolated from human infections. J. Comp. Pathol. 2004, 130, 137–142. [Google Scholar] [CrossRef]
  20. Freshwater, A. Why your housecat’s trite little bite could cause you quite a fright: A study of domestic felines on the occurrence and antibiotic susceptibility of Pasteurella multocida. Zoonoses Public Health 2008, 55, 507–513. [Google Scholar] [CrossRef] [PubMed]
  21. Perrin, I.; Blanc, P.; Karam, T.; Carbajal, R. Meningitis and osteitis caused by Pasteurella multocida in a three-month-old infant. Arch. Pediatr. 2003, 10, 439–441. [Google Scholar] [CrossRef]
  22. Chang, K.; Siu, L.K.; Chen, Y.H.; Lu, P.L.; Chen, T.C.; Hsieh, H.C.; Lin, C.L. Fatal Pasteurella multocida septicemia and necrotizing fasciitis related with wound licked by a domestic dog. Scand. J. Infect. Dis. 2007, 39, 167–170. [Google Scholar] [CrossRef]
  23. Chun, M.L.; Buekers, T.E.; Sood, A.K.; Sorosky, J.I. Postoperative wound infection with Pasteurella multocida from a pet cat. Am. J. Obstet. Gynecol. 2003, 188, 1115–1116. [Google Scholar] [CrossRef]
  24. Aziz, H.; Rhee, P.; Pandit, V.; Tang, A.; Gries, L.; Joseph, B. The current concepts in management of animal (dog, cat, snake, scorpion) and human bite wounds. J. Trauma Acute Care Surg. 2015, 78, 641–648. [Google Scholar] [CrossRef]
  25. Zbinden, R. Aggregatibacter, Capnocytophaga, Eikenella, Kingella, Pasteurella, and other fastidious or rarely encountered Gram-negative rods. In Manual of Clinical Microbiology, 11th ed.; Jorgenesen, J.H., Pfaller, M.A., Eds.; American Society for Microbiology: Washington, DC, USA, 2015; p. 652. [Google Scholar]
  26. Zangenah, S.; Güleryüz, G.; Boräng, S.; Ullberg, M.; Bergman, P.; Ozenci, V. Identification of clinical Pasteurella isolates by MALDI-TOF—A comparison with VITEK 2 and conventional microbiological methods. Diagn. Microbiol. Infect. Dis. 2013, 77, 96–98. [Google Scholar] [CrossRef]
  27. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint Tables for Interpretation of MICs and Zone Diameters. Version 11.0. 2021. Available online: http://www.eucast.org (accessed on 1 January 2021).
  28. Ujvári, B.; Gantelet, H.; Magyar, T. Development of a multiplex PCR assay for the detection of key genes associated with Pasteurella multocida subspecies. J. Vet. Diagn. Investig. 2022, 34, 319–322. [Google Scholar] [CrossRef]
  29. Hey, P.; Gow, P.; Torresi, J.; Testro, A. Cirrhosis, cellulitis and cats: A ‘purrfect’ combination for life-threatening spontaneous bacterial peritonitis from Pasteurella multocida. BMJ Case Rep. 2012, 2012, bcr2012007397. [Google Scholar] [CrossRef]
  30. Nocera, N.F.; Desai, K.K.; Granick, M.S. Cat bite cellulitis. Eplasty 2014, 14, ic25. [Google Scholar] [PubMed]
  31. Weber, D.J.; Wolfson, J.S.; Swartz, M.N.; Hooper, D.C. Pasteurella multocida infections. Report of 34 cases and review of the literature. Medicine 1984, 63, 133–154. [Google Scholar] [CrossRef] [PubMed]
  32. Holm, M.; Tärnvik, A. Hospitalization due to Pasteurella multocida-infected animal bite wounds: Correlation with inadequate primary antibiotic medication. Scand. J. Infect. Dis. 2000, 32, 181–183. [Google Scholar] [CrossRef] [PubMed]
  33. Talan, D.A.; Citron, D.M.; Abrahamian, F.M.; Moran, G.J.; Goldstein, E.J. Bacteriologic analysis of infected dog and cat bites. Emergency Medicine Animal Bite Infection Study Group. N. Engl. J. Med. 1999, 340, 85–92. [Google Scholar] [CrossRef]
  34. Wei, A.; Dhaduk, N.; Taha, B. Wrist abscess due to drug-resistant Pasteurella multocida. IDCases 2021, 26, e01277. [Google Scholar] [CrossRef]
  35. Kopita, J.M.; Handshoe, D.; Kussin, P.S.; Kelemen, M. Cat germs! Pleuropulmonary pasteurella infection in an old man. New Carol. Med. J. 1993, 54, 308–311. [Google Scholar]
  36. Kofteridis, D.P.; Christofaki, M.; Mantadakis, E.; Maraki, S.; Drygiannakis, I.; Papadakis, J.A.; Samonis, G. Bacteremic community-acquired pneumonia due to Pasteurella multocida. Int. J. Infect. Dis. 2009, 13, e81–e83. [Google Scholar] [CrossRef]
  37. Klein, N.C.; Cunha, B.A. Pasteurella multocida pneumonia. Semin. Respir. Infect. 1997, 12, 54–56. [Google Scholar]
  38. Fine, M.J.; Stone, R.A.; Singer, D.E.; Coley, C.M.; Marrie, T.J.; Lave, J.R.; Hough, L.J.; Obrosky, D.S.; Schulz, R.; Ricci, E.M.; et al. Processes and outcomes of care for patients with community-acquired pneumonia: Results from the Pneumonia Patient Outcomes Research Team (PORT) cohort study. Arch. Intern. Med. 1999, 159, 970–980. [Google Scholar] [CrossRef] [PubMed]
  39. Jan, L.; Boute, P.; Mouawad, F. Pasteurella multocida acute epiglottitis. Eur. Ann. Otorhinolaryngol. Head Neck Dis. 2021, 138, 100–102. [Google Scholar] [CrossRef] [PubMed]
  40. Moyko, A.; Ali, N.J.; Dubosh, N.M.; Wong, M.L. Pasteurella multocida Epiglottitis. Clin. Pract. Cases Emerg. Med. 2017, 1, 22–24. [Google Scholar] [CrossRef]
  41. O’Connell, K.; Fennell, J.; Callaghan, J.; Rowaiye, B.; Cormican, M. A fatal case of Pasteurella multocida epiglottitis. Ir. J. Med. Sci. 2009, 178, 541–542. [Google Scholar] [CrossRef]
  42. Tande, A.J.; Patel, R. Prosthetic joint infection. Clin. Microbiol. Rev. 2014, 27, 302–345. [Google Scholar] [CrossRef] [PubMed]
  43. Lam, P.W.; Page, A.V. Pasteurella multocida non-native joint infection after a dog lick: A case report describing a complicated two-stage revision and a comprehensive review of the literature. Can. J. Infect. Dis. Med. Microbiol. 2015, 26, 212–217. [Google Scholar] [CrossRef]
  44. Heydemann, J.; Heydemann, J.S.; Antony, S. Acute infection of a total knee arthroplasty caused by Pasteurella multocida: A case report and a comprehensive review of the literature in the last 10 years. Int. J. Infect. Dis. 2010, 14 (Suppl. S3), e242–e245. [Google Scholar] [CrossRef]
  45. Ferguson, K.B.; Bharadwaj, R.; MacDonald, A.; Syme, B.; Bal, A.M. Pasteurella multocida infected total knee arthroplasty: A case report and review of the literature. Ann. R. Coll. Surg. Engl. 2014, 96, e1–e4. [Google Scholar] [CrossRef]
  46. Honnorat, E.; Seng, P.; Savini, H.; Pinelli, P.O.; Simon, F.; Stein, A. Prosthetic joint infection caused by Pasteurella multocida: A case series and review of literature. BMC Infect. Dis. 2016, 16, 435. [Google Scholar] [CrossRef]
  47. French, B.; Myers, J.P. Pubic Symphysis Septic Arthritis Caused by Pasteurella multocida: Report of the First Known Case and Review of the Literature. Infect. Dis. Clin. Pract. 2020, 28, e1–e2. [Google Scholar] [CrossRef]
  48. Guet-Revillet, H.; Levy, C.; Andriantahina, I.; Kalach, N.; Pierre, M.H.; Elbez-Rubinstein, A.; Boniface, C.; Berche, P.; Cohen, R.; Ferroni, A. Paediatric epidemiology of Pasteurella multocida meningitis in France and review of the literature. Eur. J. Clin. Microbiol. Infect. Dis. 2013, 32, 1111–1120. [Google Scholar] [CrossRef] [PubMed]
  49. Kumar, A.; Devlin, H.R.; Vellend, H. Pasteurella multocida meningitis in an adult: Case report and review. Rev. Infect. Dis. 1990, 12, 440–448. [Google Scholar] [CrossRef] [PubMed]
  50. Green, B.T.; Ramsey, K.M.; Nolan, P.E. Pasteurella multocida meningitis: Case report and review of the last 11 y. Scand. J. Infect. Dis. 2002, 34, 213–217. [Google Scholar] [CrossRef]
  51. McKelvie, B.; Smith, J.; Macdonald, N. Case 1: Man’s best friend? Paediatr. Child Health 2013, 18, 305–306. [Google Scholar]
  52. Kawashima, S.; Matsukawa, N.; Ueki, Y.; Hattori, M.; Ojika, K. Pasteurella multocida meningitis caused by kissing animals: A case report and review of the literature. J. Neurol. 2010, 257, 653–654. [Google Scholar] [CrossRef]
  53. Katechakis, N.; Maraki, S.; Dramitinou, I.; Marolachaki, E.; Koutla, C.; Ioannidou, E. An unusual case of Pasteurella multocida bacteremic meningitis. J. Infect. Public Health 2019, 12, 95–96. [Google Scholar] [CrossRef]
  54. Khan, M.F.; Movahed, M.R.; Jung, J. Pasteurella multocida endocarditis. J. Heart Valve Dis. 2012, 21, 260–262. [Google Scholar]
  55. Mikaberidz, N.; Li, E.Y.; Taub, C.C. Pasteurella multocida infective endocarditis in an immunocompetent patient complicated by rhabdomyolysis and permanent hearing loss. J. Cardiovasc. Dis. Res. 2013, 4, 55–57. [Google Scholar] [CrossRef]
  56. Porter, R.S.; Hay, C.M. Pasteurella Endocarditis: A Case Report and Statistical Analysis of the Literature. Case Rep. Infect. Dis. 2020, 2020, 8890211. [Google Scholar] [CrossRef]
  57. Sin Fai Lam, K.N.; Mah, P.K.; Chuah, S.C.; Chew, L.S. Pasteurella multocida septicaemia following a dog bite. Singap. Med. J. 1993, 34, 271–273. [Google Scholar]
  58. Al-Allaf, A.K.; Harvey, T.C.; Cunnington, A.R. Pericardial tamponade caused by Pasteurella multocida infection after a cat bite. Postgrad. Med. J. 2001, 77, 199–200. [Google Scholar] [CrossRef] [PubMed]
  59. Rachina, S.A.; Mukhina, N.V.; Cherkasova, N.A.; Komarova, I.S.; Ushakova, O.E.; Nasrulloeva, S.M.; Burmistrova, E.N.; Ivanchik, N.V. Unexpected clinical case of Pasteurella multocida infectious endocarditis in a patient with iv drug abuse: Why epidemiological history matters. Germs 2022, 12, 130–136. [Google Scholar] [CrossRef] [PubMed]
  60. Hanson, J.; Etemady-Deylamy, A.; Frisby, J.; D’Addario, J.; Smeds, M.; Chamberland, R.; Guo, H.; Abate, G. Femoral artery aneurysm with large hematoma from Pasteurella: Case report and literature review. BMC Infect. Dis. 2022, 22, 170. [Google Scholar] [CrossRef] [PubMed]
  61. Jeng, E.I.; Acosta, G.; Martin, T.D.; Upchurch, G.R., Jr. Pasteurella multiocida infection resulting in a descending thoracic aorta mycotic pseudoaneurysm. J. Card. Surg. 2020, 35, 2070–2072. [Google Scholar] [CrossRef] [PubMed]
  62. Kimura, R.; Hayashi, Y.; Takeuchi, T.; Shimizu, M.; Iwata, M.; Tanahashi, J.; Ito, M. Pasteurella multocida septicemia caused by close contact with a domestic cat: Case report and literature review. J. Infect. Chemother. 2004, 10, 250–252. [Google Scholar] [CrossRef] [PubMed]
  63. Narsana, N.; Farhat, F. Septic shock due to Pasteurella multocida bacteremia: A case report. J. Med. Case Rep. 2015, 9, 159. [Google Scholar] [CrossRef] [PubMed]
  64. Talley, P.; Snippes-Vagnone, P.; Smith, K. Invasive Pasteurella multocida Infections—Report of Five Cases at a Minnesota Hospital, 2014. Zoonoses Public Health 2016, 63, 431–435. [Google Scholar] [CrossRef]
  65. Fajfar-Whetstone, C.J.; Coleman, L.; Biggs, D.R.; Fox, B.C. Pasteurella multocida septicemia and subsequent Pasteurella dagmatis septicemia in a diabetic patient. J. Clin. Microbiol. 1995, 33, 202–204. [Google Scholar] [CrossRef]
  66. Borges, L.; Oliveira, N.; Cássio, I.; Costa, H. Sepsis-induced purpura fulminans caused by Pasteurella multocida. BMJ Case Rep. 2014, 2014, bcr2013202441. [Google Scholar] [CrossRef]
  67. Aljameely, A.; Wali, G. Pasteurella multocida Septic Shock: Case Report and Literature Review. Case Rep. Infect. Dis. 2019, 2019, 1964161. [Google Scholar] [CrossRef]
  68. Caserza, L.; Piatti, G.; Bonaventura, A.; Liberale, L.; Carbone, F.; Dallegri, F.; Ottonello, L.; Gustinetti, G.; Del Bono, V.; Montecucco, F. Sepsis by Pasteurella multocida in an Elderly Immunocompetent Patient after a Cat Bite. Case Rep. Infect. Dis. 2017, 2017, 2527980. [Google Scholar] [CrossRef] [PubMed]
  69. Okumura, H.; Nishiguchi, S. Pasteurella multocida Infection Presented With Frequent Diarrhea in the Cirrhotic Patient. Cureus 2021, 13, e18183. [Google Scholar] [CrossRef]
  70. Mu, H.; Yang, M.; Zhang, Y.; Zhang, Y.; Wang, J.; Yuan, W.; Rong, S. Pet-related Pasteurella multocida induced peritonitis in peritoneal dialysis: A case report and review of the literatures. BMC Nephrol. 2020, 21, 102. [Google Scholar] [CrossRef] [PubMed]
  71. Satomura, A.; Yanai, M.; Fujita, T.; Arashima, Y.; Kumasaka, K.; Nakane, C.; Ito, K.; Fuke, Y.; Maruyama, T.; Maruyama, N.; et al. Peritonitis associated with Pasteurella multocida: Molecular evidence of zoonotic etiology. Ther. Apher. Dial. 2010, 14, 373–376. [Google Scholar] [CrossRef] [PubMed]
  72. Al-Fifi, Y.S.; Sathianathan, C.; Murray, B.L.; Alfa, M.J. Pets are ‘risky business’ for patients undergoing continuous ambulatory peritoneal dialysis. Can. J. Infect. Dis. Med. Microbiol. 2013, 24, e96–e98. [Google Scholar] [CrossRef] [PubMed]
  73. Abreu, F.; Rodríguez-Lucas, C.; Rodicio, M.R.; Vela, A.I.; Fernández-Garayzábal, J.F.; Leiva, P.S.; Cuesta, F.; Cid, D.; Fernández, J. Human Pasteurella multocida Infection with Likely Zoonotic Transmission from a Pet Dog, Spain. Emerg. Infect. Dis. 2018, 24, 1145–1146. [Google Scholar] [CrossRef]
  74. Baykara, Y.; Dogon, C.; McCormick, W.; Siegert, T.; Hong, T. Pasteurella multocida Urinary Tract Infection in a Susceptible Patient with Non-Traumatic Feline Contact. Rhode Isl. Med. J. 2022, 105, 17–19. [Google Scholar]
  75. Christenson, E.S.; Ahmed, H.M.; Durand, C.M. Pasteurella multocida infection in solid organ transplantation. Lancet Infect. Dis. 2015, 15, 235–240. [Google Scholar] [CrossRef]
  76. Nagata, H.; Yamada, S.; Uramaru, K.; Kiyasu, Y.; Kano, N. Acute cholecystitis with bacteremia caused by Pasteurella multocida. Surg. Infect. 2014, 15, 72–74. [Google Scholar] [CrossRef]
  77. Hoffman, M.E.; Sorr, E.M.; Barza, M. Pasteurella multocida endophthalmitis. Br. J. Ophthalmol. 1987, 71, 609–610. [Google Scholar] [CrossRef]
  78. Acay, M.C.; Oral, E.T.; Yenigün, M.; Sahin, A. Pasteurella multocida ulceration on the penis. Int. J. Dermatol. 1993, 32, 519–520. [Google Scholar] [CrossRef] [PubMed]
  79. Wright, G.; Muir, M.L.; Bryan, R.; Smith, A.J.; Hosey, M.T. Dental follicle infection following a dog bite. Int. J. Paediatr. Dent. 2006, 16, 147–150. [Google Scholar] [CrossRef] [PubMed]
  80. Loïez, C.; Wallet, F.; Husson, M.O.; Courcol, R.J. Pasteurella multocida and intrauterine device: A woman and her pets. Scand. J. Infect. Dis. 2002, 34, 473. [Google Scholar] [CrossRef] [PubMed]
  81. Hasan, J.; Hug, M. Pasteurella multocida; StatPearls Publishing: Treasure Island, FL, USA, 2023. [Google Scholar]
  82. Kannikeswaran, N.; Kamat, D. Mammalian bites. Clin. Pediatr. 2009, 48, 145–148. [Google Scholar] [CrossRef] [PubMed]
  83. Stevens, D.L.; Bisno, A.L.; Chambers, H.F.; Dellinger, E.P.; Goldstein, E.J.; Gorbach, S.L.; Hirschmann, J.V.; Kaplan, S.L.; Montoya, J.G.; Wade, J.C. Infectious Diseases Society of America: Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 2015, 60, 1448. [Google Scholar] [CrossRef]
  84. Naas, T.; Benaoudia, F.; Lebrun, L.; Nordmann, P. Molecular identification of TEM-1 beta-lactamase in a Pasteurella multocida isolate of human origin. Eur. J. Clin. Microbiol. Infect. Dis. 2001, 20, 210–213. [Google Scholar] [CrossRef]
  85. Seki, M.; Sakata, T.; Toyokawa, M.; Nishi, I.; Tomono, K. A Chronic Respiratory Pasteurella multocida Infection Is Well-Controlled by Long-Term Macrolide Therapy. Intern. Med. 2016, 55, 307–310. [Google Scholar] [CrossRef]
  86. Tabaka, M.E.; Quinn, J.V.; Kohn, M.A.; Polevoi, S.K. Predictors of infection from dog bite wounds: Which patients may benefit from prophylactic antibiotics? Emerg. Med. J. 2015, 32, 860–863. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Piorunek, M.; Brajer-Luftmann, B.; Walkowiak, J. Pasteurella Multocida Infection in Humans. Pathogens 2023, 12, 1210. https://doi.org/10.3390/pathogens12101210

AMA Style

Piorunek M, Brajer-Luftmann B, Walkowiak J. Pasteurella Multocida Infection in Humans. Pathogens. 2023; 12(10):1210. https://doi.org/10.3390/pathogens12101210

Chicago/Turabian Style

Piorunek, Marcin, Beata Brajer-Luftmann, and Jarosław Walkowiak. 2023. "Pasteurella Multocida Infection in Humans" Pathogens 12, no. 10: 1210. https://doi.org/10.3390/pathogens12101210

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop